DIFFUSION PHARMACEUTICALS IN (DFFN)

US2537484048 - Common Stock

4.4  +0.46 (+11.68%)

After market: 4.46 +0.06 (+1.36%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 TTM
(2023-6-30)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-13.08M-15.59M-24.10M-14.19M-11.80M
Depreciation Amortization
N/A0.0093.42K103.17K100.00K
Income Taxes - Deferred
N/A0.00-443.89K-1.68M330.00K
Change In Working Capital
-1.10M-97.16K356.37K1.47M990.00K
Interest Paid
N/AN/AN/AN/A0.00
Other non cash items
335.01K719.48K9.59M736.12K520.00K
OPERATING CASH FLOW
-13.85M-14.97M-14.50M-13.55M-9.86M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/AN/AN/AN/AN/A
Other Investing Activity
22.88M-12.24M4.00KN/AN/A
INVESTING CASH FLOW
22.88M-12.24M4.00KN/AN/A
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/AN/AN/A0.00
Stock Issued/Repurchased
0.005.00K33.30M18.87M16.21M
Other Financing Activity
N/AN/A0.00-982.33K-160.00K
FINANCING CASH FLOW
0.005.00K33.30M17.89M16.04M
 
CHANGE IN CASH
9.03M-27.20M18.80M4.34M6.19M
 
FREE CASH FLOW
Operating Cash Flow
-13.85M-14.97M-14.50M-13.55M-9.86M
Capital Expenditure
N/AN/AN/AN/AN/A
FREE CASH FLOW
-13.85M-14.97M-14.50M-13.55M-9.86M

All data in USD

Charts